Our goal is to end the epidemic of liver cancer and liver failure in Texas through early detection and treatment of hepatitis C virus (HCV), a leading cause of hepatocellular carcinoma (HCC). Through one-time screening for all adults ages 18-79 for HCV we aim to
Screen, Treat, Or Prevent (STOP) HCC and HCV.
STOP HCC-HCV is funded by the Cancer Prevention Research Institute of Texas (CPRIT), to offer education about HCV and HCC, promote screening, and support management of patients who are chronically infected.
Our program operates in primary care settings across rural South Texas and the Dallas region, helping practices to screen for HCV and deliver high-quality care for those with chronic HCV infection.
STOP HCC-HCV offers healthcare providers and staff education and resources about HCV and HCC. We offer effective tools and strategies for HCV screening and treatment including provider telementoring and resources for patients who are uninsured/underinsured.
STOP HCC-HCV promotes public awareness about this common disease that causes liver failure and liver cancer with educational programs, presentations, and webinars across Texas.
Key components:
- Interactive patient education about HCV epidemiology, risk factors, and healthy decisions using a mobile app in Spanish and English
- Personalized patient counseling about HCV and care navigation by certified community health workers and clinical staff
- Counseling services such as alcohol counseling and changing lifestyle to reduce liver disease risks
- Liver disease staging and evaluation for primary care management and treatment of HCV with teleconsultation support by an infectious disease specialist
The STOP HCC-HCV program is conducted through a partnership between the Center for Research to Advance Community Health (ReACH) and the School of Nursing at UT Health San Antonio
